SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-21-000024
Filing Date
2021-11-15
Accepted
2021-11-15 07:11:18
Documents
15
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20211115.htm   iXBRL 8-K 39111
2 EX-99.1 cntapressrelease2021093011.htm EX-99.1 82178
7 centessalogoa.jpg GRAPHIC 122156
  Complete submission text file 0001847903-21-000024.txt   494569

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20211115.xsd EX-101.SCH 2745
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20211115_def.xml EX-101.DEF 16935
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20211115_lab.xml EX-101.LAB 33041
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20211115_pre.xml EX-101.PRE 17742
8 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20211115_htm.xml XML 14581
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 211406277
SIC: 2834 Pharmaceutical Preparations